Philippe Chambon

Philippe Chambon

..................................

Managing Director

New York

Philippe Chambon is a Managing Director and concentrates on healthcare information convergence and biopharmaceutical investments. He joined the Sprout Group in 1995 and became a General Partner in 1997 before becoming one of the founders of New Leaf in 2005. Over his career, he has invested broadly in healthcare technology companies across multiple sectors and stages of development.

He is currently on the Advisory Board of the New York Digital Health Accelerator, which is run in partnership with the New York eHealth Collaborative as well as the Advisory Board of the BioAccelerate NYC program of the Partnership Fund for New York City.

Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from 1993 to 1995. From 1987 to 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a M.D., Ph.D. from the University of Paris. Philippe also has an M.B.A. from Columbia University in New York.

Karos Pharmaceuticals
Qpid Health
Treato
Truveris
VaxInnate

Principia Biopharma

Audax Health Solutions (Acquired by Optum/UnitedHealth)
Auxilium Pharmaceuticals (AUXL)
Cephalon
Charles River Labs
ePocrates (EPOC, Acquired by athenahealth)
Focus Diagnostics (Acquired by Quest Diagnostics)
Nuvelo
Pharsight Corp. (NASDAQ: PHST, Acquired by Tripos)
Phase Forward (NASDAQ: PFWD, Acquired by Oracle)
Sapient Health Networks (Acquired by WebMD)
Spotfire (Acquired by Tibco)


(646) 871-6400